APPLICATION
ANDA090313
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-21
LATEST ACTION
2020-02-25
ROUTE
ORAL, RECTAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
SODIUM POLYSTYRENE SULFONATEPrescription
SODIUM POLYSTYRENE SULFONATE 453.6GM/BOT · POWDER · ORAL, RECTAL
Approval history
2020-02-25Labeling · Supplement 2 · standardAP
2011-12-21OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.